Furthermore, studies have found that a lower CD4+/CD8+ ratio at diagnosis is linked to poor prognosis in patients with multiple myeloma and Waldenström’s macroglobulinemia (23, 24). The gene discussed is CD8A; the disease is plasma cell myeloma.